AstraZeneca-Oxford vaccine more effective with longer dose gap, study suggests

AstraZeneca-Oxford vaccine more effective with longer dose gap, study suggests

NIAC has said the AstraZeneca vaccine will only be administered to adults under the age of 70 in the State, despite the World Health Organization recommending it for all adults over 18, due to a lack of data regarding its efficacy among older people. They are being given the Chinese-made Sinopharm vaccine, which is a two-dose vaccine with an efficacy of 78.6%. "In the long term, a second dose should ensure long-lived immunity, and so we encourage everyone who has had their first vaccine to ensure they receive both doses".

The slow rollout has been blamed on a range of national problems as well as delayed approval of the vaccines compared to elsewhere and an initial shortage of supply. He said so far 52,000 health workers have been vaccinated. He also urged people above the age of 65 to start registering themselves for the vaccine for the second phase, which he said would start from March. Factors associated with this include the effect of different intervals on protection after the second dose, and the risk of infection between doses either due to lower efficacy of a single dose or rapid waning of efficacy while waiting for the second dose. They combined data from clinical trials in the UK, Brazil, and South Africa, which together included a total of 17,178 adult participants.

The government has not advised this vaccine for people above 65 years.

EXPLAINER: What's up between Google, Facebook and Australia?
Some of the blocked pages were later restored, though even Facebook's own page was briefly taken down . Australian citizens have voiced their anger at Facebook's decision.

Oxford University's COVID-19 vaccine for emergency use, widening access to the relatively cheap shot in the developing world.

In a statement retweeted by Health Minister Jens Spahn, the Paul Ehrlich Institute (PEI) said the vaccine "prevents COVID-19 disease in the majority of cases or alleviates symptoms when disease occurs".

Scientist wey do di Oxford-AstraZeneca vaccine take adenovirus wey dey for Chimpanzee come modify am so e go train di immune system to seriously fight against di SARS-CoV-2 virus wey dey cause Covid-19.

Related Articles